SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Citigroup Global Markets India informs about Post Open Offer Status

24 Jul 2015 Evaluate

Citigroup Global Markets India (‘Manager to the Offer’), on behalf of Sun Pharmaceutical Industries Limited (‘Sun Pharma’/ ‘Acquirer’), has informed this Post Offer Announcement to the Shareholders of Zenotech Laboratories Limited (‘Zenotech’ / ‘Target Company’), pursuant to Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (‘SEBI (SAST) Regulations’) in respect of the open offer (‘Offer’) for acquisition of up to 9,693,332  fully paid up equity shares (Shares) representing 28.16% of the fully diluted share capital of the Target Company, pursuant to and in compliance with Regulations 3(1), 4 and 5(1) of the SEBI (SAST) Regulations.This Announcement should be read in continuation and in conjunction with the Public Announcement dated April 11, 2014 (PA), the Detailed Public Statement with respect to the aforementioned Offer dated March 30, 2015 (DPS), the Letter of Offer dated June 18, 2015 (Letter of Offer), and the Offer Opening Advertisement published on June 29, 2015.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1670.35 -4.85 (-0.29%)
20-Apr-2026 12:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.35
Dr. Reddys Lab 1236.85
Cipla 1232.80
Zydus Lifesciences 942.40
Lupin 2332.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×